Group 1 - The core point of the article is that Weifeng Electronics (SZ 301328) held its 20th meeting of the second board of directors on October 24, 2025, to discuss various proposals, including the independent director's allowance for the third board [1] - For the fiscal year 2024, Weifeng Electronics reported that 99.03% of its revenue came from connectors, while other businesses contributed 0.97% [1] - As of the report, Weifeng Electronics has a market capitalization of 5.1 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing deals this year, indicating a booming secondary market in biomedicine [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, reveals that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]